What We Learn From Clinical Trials

04.04.13 | By

A recent op-ed in Forbes offers a welcome rebuttal to misguided criticism of the conduct of clinical trials by the biopharmaceutical industry by refuting the notion that "medicine is broken" partly due to the hiding of "negative" clinical trial results.

Development of Biopharmaceuticals

04.01.13 | By

Today, we are pleased to have a guest blog post on incremental innovation from Eric A. Utt, Ph.D., Director, Worldwide Policy for Pfizer.

Over 8,200 Clinical Trials of Medicines Conducted by Texas Research Institutions Since 1999


Medicines in Development

Each patient battling with a disease or managing a condition lives in the hope that tomorrow will bring a new medicine that delivers better health. America’s biopharmaceutical research companies share the same goal of developing new medicines that can prevent diseases, improve patients’ health, and save lives. Beyond each individual patient, new drugs can help society overall by reducing sick days and helping cut the cost of healthcare.

Innovation Hub

Medical innovation from America’s biopharmaceutical research companies continues to help patients live longer, healthier, and more productive lives. Most of us are familiar with the landmark innovations that have defined our health care landscape. What few of us understand, however, are the processes and complexities that lead to biopharmaceutical advances, or the many moving parts and contributors that make progress possible.

Research in Your Backyard

There’s a good chance you can find a clinical trial taking place practically in your own backyard. Biopharmaceutical companies are conducting clinical trials of new medicines in collaboration with clinical research centers, university medical schools and hospitals all across the country. These trials provide patients with access to new potential therapeutic options.

Intellectual Property


Innovation—it is what everyone likes to talk about, but what does it really mean for millions of patients battling disease? Simply put, medical innovation can help patients live longer, healthier and more productive lives.

More Than 400 Innovative Medicines in Development For Top Chronic Diseases Affecting Older Americans

WASHINGTON, D.C. (March 20, 2013) – America’s biopharmaceutical research companies are developing 465 new medicines that target the 10 leading chronic conditions affecting seniors, according to a new report and overview released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

With the population of Americans over 65 on the rise and life expectancy climbing, chronic diseases remain a principal threat to the health and productivity of older Americans, as well as to rising health care costs. Innovative medicines have led to major advances against many chronic diseases – and the robust discovery pipeline of new medicines portends continued progress for seniors and our health care system.

Medicines in Development for Older Americans - Clinical Trial Backgrounder

The 668 clinical trials listed here include 406 that have not yet started recruiting patients or are just now seeking volunteers to participate and another 262 that are active, but not recruiting new patients. This information is potentially valuable to patients still seeking effective treatments for the top ten chronic diseases affecting seniors. It provides a new therapeutic option to discuss with physicians.


Subscribe to RSS - Innovation